LDLR and metabolic dysfunction-associated steatotic liver disease: In addition, many molecular processes that underlie the pathogenesis in NAFLD patients (both on the level of liver transcriptomics and of plasma metabolomics) are also reflected in the Ldlr-/-.Leiden mouse (32–34).